Literature DB >> 31865058

Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder.

C J Banta-Green1, J R Williams2, J M Sears3, A S Floyd4, J I Tsui5, T J Hoeft6.   

Abstract

INTRODUCTION: Opioid use disorder (OUD) is common among people in jail and is effectively treated with medications for OUD (MOUD). People with OUD may have an incomplete or inaccurate understanding of OUD and MOUD, and of how to access care. We evaluated an OUD treatment decision making (TDM) intervention to determine whether the intervention increased MOUD initiation post-release.
METHODS: We conducted an observational retrospective cohort study of the TDM intervention on initiation of MOUD, individuals with records data indicating confirmed or suspected OUD incarcerated in four eligible jails were eligible to receive the intervention. Time-to-event analyses of the TDM intervention were conducted using Cox proportional hazard modeling with MOUD as the outcome.
RESULTS: Cox proportional hazard modeling, with the intervention modeled as having a time-varying effect due to violation of the proportionality assumption, indicated that those receiving the TDM intervention (n = 568) were significantly more likely to initiate MOUD during the first month after release from jail (adjusted hazard ratio 6.27, 95 % C.I. 4.20-9.37), but not in subsequent months (AHR 1.33 95 % C.I. 0.94-1.89), adjusting for demographics, prior MOUD, or felony or gross misdemeanor arrest in the prior year compared to those not receiving the intervention (n = 3174).
CONCLUSION: The TDM intervention was associated with a significantly higher relative hazard of starting MOUD, specifically during the first month after incarceration. However, a minority of all eligible people received any MOUD. Future research should examine ways to increase initiation on MOUD immediately after (or ideally during) incarceration.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Buprenorphine; Decision-making; Jail; Methadone; Naltrexone; Opioid; Treatment

Mesh:

Substances:

Year:  2019        PMID: 31865058      PMCID: PMC8085903          DOI: 10.1016/j.drugalcdep.2019.107799

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  36 in total

1.  Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

Authors:  Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser
Journal:  Health Serv Res       Date:  2006-02       Impact factor: 3.402

2.  A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients.

Authors:  Sharon M Kelly; Barry S Brown; Elizabeth C Katz; Kevin E O'Grady; Shannon Gwin Mitchell; Stuart King; Robert P Schwartz
Journal:  Am J Drug Alcohol Abuse       Date:  2012-01-13       Impact factor: 3.829

3.  The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine.

Authors:  Robin E Clark; Mihail Samnaliev; Jeffrey D Baxter; Gary Y Leung
Journal:  Health Aff (Millwood)       Date:  2011-08       Impact factor: 6.301

4.  Hospitalized opioid-dependent patients: Exploring predictors of buprenorphine treatment entry and retention after discharge.

Authors:  Christina S Lee; Jane M Liebschutz; Bradley J Anderson; Michael D Stein
Journal:  Am J Addict       Date:  2017-03-21

5.  Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.

Authors:  Kate A Dolan; James Shearer; Bethany White; Jialun Zhou; John Kaldor; Alex D Wodak
Journal:  Addiction       Date:  2005-06       Impact factor: 6.526

6.  Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.

Authors:  Caleb J Banta-Green; Charles Maynard; Thomas D Koepsell; Elizabeth A Wells; Dennis M Donovan
Journal:  Addiction       Date:  2009-03-13       Impact factor: 6.526

7.  Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.

Authors:  Joshua D Lee; Edward V Nunes; Patricia Novo; Ken Bachrach; Genie L Bailey; Snehal Bhatt; Sarah Farkas; Marc Fishman; Phoebe Gauthier; Candace C Hodgkins; Jacquie King; Robert Lindblad; David Liu; Abigail G Matthews; Jeanine May; K Michelle Peavy; Stephen Ross; Dagmar Salazar; Paul Schkolnik; Dikla Shmueli-Blumberg; Don Stablein; Geetha Subramaniam; John Rotrosen
Journal:  Lancet       Date:  2017-11-14       Impact factor: 79.321

8.  Attitudes toward buprenorphine and methadone among opioid-dependent individuals.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Shannon Gwin Mitchell; James A Peterson; Heather Schacht Reisinger; Michael H Agar; Barry S Brown
Journal:  Am J Addict       Date:  2008 Sep-Oct

9.  A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease.

Authors:  Timothy W Kinlock; Michael S Gordon; Robert P Schwartz; Terrence T Fitzgerald; Kevin E O'Grady
Journal:  J Subst Abuse Treat       Date:  2009-03-31

10.  Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.

Authors:  Aaron D Fox; Jeronimo Maradiaga; Linda Weiss; Jennifer Sanchez; Joanna L Starrels; Chinazo O Cunningham
Journal:  Addict Sci Clin Pract       Date:  2015-01-16
View more
  2 in total

1.  Decisional considerations for methadone uptake in Kyrgyz prisons: The importance of understanding context and providing accurate information.

Authors:  Amanda R Liberman; Daniel J Bromberg; Lyuba Azbel; Julia Rozanova; Lynn Madden; Jaimie P Meyer; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2021-04-07

2.  Role of the Intersections of Gender, Race and Sexual Orientation in the Association between Substance Use Behaviors and Sexually Transmitted Infections in a National Sample of Adults with Recent Criminal Legal Involvement.

Authors:  Tyler D Harvey; Ijeoma Opara; Emily A Wang
Journal:  Int J Environ Res Public Health       Date:  2022-03-30       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.